Significant upregulation was observed for the mRNA expression of B7-H3 (CD276), a member of the B7 family that plays an immunoregulatory role in the T-cell response, highlighting this molecule as a novel potential target for cancer immunotherapy [45,46]. The gene discussed is CD276; the disease is cancer.